Severe COVID-19 in patients with hematological cancers presenting with viremia
Ann Oncol
.
2021 Oct;32(10):1297-1300.
doi: 10.1016/j.annonc.2021.07.002.
Epub 2021 Jul 13.
Authors
J M Michot
1
,
T Hueso
2
,
N Ibrahimi
3
,
F Pommeret
4
,
C Willekens
2
,
E Colomba
4
,
S Francis
5
,
A Bayle
4
,
P H Cournède
6
,
M Merad
7
,
S Foulon
3
,
L Albiges
4
,
B Gachot
7
,
F Barlesi
8
,
J C Soria
9
,
V Ribrag
2
,
F Griscelli
5
Affiliations
1
Hematology Department, Gustave Roussy, Paris-Saclay University, Paris, France. Electronic address:
[email protected]
.
2
Hematology Department, Gustave Roussy, Paris-Saclay University, Paris, France.
3
Biostatistics Department, Gustave Roussy, Paris-Saclay University, Paris, France.
4
Cancer Medicine Department, Gustave Roussy, Paris-Saclay University, Paris, France.
5
Biopathology Department, Gustave Roussy, Paris-Saclay University, Paris, France.
6
Lab MICS, Centrale Supélec, Paris-Saclay University, Paris, France.
7
Interdisciplinary Cancer Course Department, Gustave Roussy, Paris-Saclay University, Paris, France.
8
Gustave Roussy, Paris-Saclay University, Paris, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.
9
Gustave Roussy, Paris-Saclay University, Paris, France.
PMID:
34265373
PMCID:
PMC8275471
DOI:
10.1016/j.annonc.2021.07.002
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Hematologic Neoplasms* / complications
Hospitalization
Humans
SARS-CoV-2
Viremia / complications